Sale!

PPP1R17 Gene Hypercholesterolemia Susceptibility to Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The PPP1R17 gene, associated with the regulation of lipid metabolism pathways, has recently been identified as a potential factor influencing an individual’s susceptibility to hypercholesterolemia. Hypercholesterolemia, characterized by high levels of cholesterol in the blood, significantly increases the risk of cardiovascular diseases. Understanding the genetic predisposition to this condition can be crucial in its early detection and management.

DNA Labs UAE offers a specialized genetic test targeting the PPP1R17 gene to assess the risk of developing hypercholesterolemia. This test is particularly recommended for individuals with a family history of hypercholesterolemia or cardiovascular diseases, aiming to provide a personalized risk assessment that can guide lifestyle and medical interventions.

The test is priced at 4400 AED, reflecting the sophisticated technology and expertise involved in analyzing the genetic markers associated with hypercholesterolemia susceptibility. Conducted in a state-of-the-art laboratory setting, the process involves collecting a DNA sample, typically through a non-invasive method such as a saliva swab or blood draw, followed by a detailed analysis of the PPP1R17 gene.

Results from this test can offer valuable insights into an individual’s genetic predisposition to hypercholesterolemia, enabling proactive health management strategies. It is, however, important to note that genetic predisposition is just one of many factors that can contribute to the development of hypercholesterolemia, and results should be interpreted in conjunction with other clinical assessments and lifestyle considerations.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PPP1R17 Gene Hypercholesterolemia Susceptibility Genetic Test

Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Metabolic Disorders
  • Doctor: General Physician
  • Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for PPP1R17 Gene Hypercholesterolemia, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Hypercholesterolemia, susceptibility to.

Test Details

The PPP1R17 gene is associated with susceptibility to hypercholesterolemia, which is a condition characterized by high levels of cholesterol in the blood. NGS (Next-Generation Sequencing) is a genetic testing method that allows for the sequencing of multiple genes simultaneously, providing a comprehensive analysis of an individual’s genetic makeup.

NGS genetic testing for PPP1R17 gene hypercholesterolemia susceptibility involves analyzing the DNA of an individual to identify any variations or mutations in the PPP1R17 gene that may contribute to an increased risk of developing hypercholesterolemia. This information can help healthcare professionals in assessing an individual’s risk of developing the condition and determining appropriate management strategies.

It is important to note that a positive result for PPP1R17 gene hypercholesterolemia susceptibility does not necessarily mean that an individual will develop hypercholesterolemia. Genetic testing provides valuable information about an individual’s genetic predisposition, but other factors such as lifestyle choices and environmental influences also play a role in the development of the condition.

It is recommended to consult with a healthcare professional or a genetic counselor to understand the implications of the test results and to discuss appropriate management strategies based on the individual’s specific genetic profile and overall health.

Test Name PPP1R17 Gene Hypercholesterolemia susceptibility to Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PPP1R17 Gene Hypercholesterolemia, susceptibility to NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Hypercholesterolemia, susceptibility to
Test Details

The PPP1R17 gene is associated with susceptibility to hypercholesterolemia, which is a condition characterized by high levels of cholesterol in the blood. NGS (Next-Generation Sequencing) is a genetic testing method that allows for the sequencing of multiple genes simultaneously, providing a comprehensive analysis of an individual’s genetic makeup.

NGS genetic testing for PPP1R17 gene hypercholesterolemia susceptibility involves analyzing the DNA of an individual to identify any variations or mutations in the PPP1R17 gene that may contribute to an increased risk of developing hypercholesterolemia. This information can help healthcare professionals in assessing an individual’s risk of developing the condition and determining appropriate management strategies.

It is important to note that a positive result for PPP1R17 gene hypercholesterolemia susceptibility does not necessarily mean that an individual will develop hypercholesterolemia. Genetic testing provides valuable information about an individual’s genetic predisposition, but other factors such as lifestyle choices and environmental influences also play a role in the development of the condition.

It is recommended to consult with a healthcare professional or a genetic counselor to understand the implications of the test results and to discuss appropriate management strategies based on the individual’s specific genetic profile and overall health.